🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Status
Completed
Location
Zhejiang Province Cancer Hospital
Start Date
2022-07-01
Trial ID
NCT06378580
Treatments Being Tested
To explore the efficacy and safety of surufatinib in combination with AG re...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-03-03
Trial ID
NCT07436741
Treatments Being Tested
To evaluate the efficacy and safety of surufatinib combined with gemcitabin...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-06-01
Trial ID
NCT06361030
Treatments Being Tested
This is a single-center, prospective, two cohort study to evaluate the effi...
Status
Recruiting
Location
Fudan University ShangHai Cancer Center
Start Date
2023-12-05
Trial ID
NCT05969171
Treatments Being Tested
This is a single-center, single-arm, open-label, phase 2 clinical study, to...
Status
Active Not Recruiting
Location
Cancer center of SunYat-sen University
Start Date
2022-12-12
Trial ID
NCT05481476
Treatments Being Tested
This study is designed to explore the efficacy and safety of surufatinib co...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2021-08-04
Trial ID
NCT05218889
Treatments Being Tested
To evaluate the efficacy of surufatinib combined with camrelizumab, nab-pac...
Status
Recruiting
Location
Nanjing Tianyinshan Hospital
Start Date
2024-05-08
Trial ID
NCT06361888
This study is designed to explore the efficacy and safety of surufatinib co...
Status
Completed
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2023-05-31
Trial ID
NCT05908747
Treatments Being Tested
Advanced pancreatic cancer is a highly aggressive and fatal disease with an...
Status
Unknown
Location
Zhongshan Hospital
Start Date
2023-11-01
Trial ID
NCT05832892
Treatments Being Tested